Separation & Purification Patents: Top Companies & Filing Trends 2026
- Filing has pulled back 21% since 2021. 2021 filings (330) fell to 260 by 2024 — the last year clean of publication-lag distortion — a meaningful cool-down after the 2020 peak of 388.
- No single filer dominates. The leader holds 689 records but the top 5 combined account for just 14.2% of all 11,323 records in scope, and the top 10 only 19.8% — concentration is shallow.
- Catalysis and separation overlap heavily with fermentation. C07C compounds (23.1%) and B01J catalysis (18.3%) lead, but C12P fermentation (10.0%) and C12N microorganisms (7.1%) show biological routes are a real, separately-claimed track.
Filing growth compares 2021 (330 records) with 2024 (260) — a three-year span. 2024 is the most recent year we treat as complete: publication lags filing by roughly 18 months, so 2025 onwards are still filling in and any growth rate that ends there would understate the field. Top-5 share is the combined record count of the five largest assignees divided by all 11,323 records in scope (CR5), not by the ranked leaders only.
What this landscape covers
The corpus spans 11,323 published records filed against separation, purification and mass-transfer process claims — spanning acyclic and carbocyclic chemistry, catalytic processing, fermentation routes and separation hardware. Coverage runs from 2015 through the 2026-08-31 data cut-off, so the most recent filing years are still filling in as publications catch up with filing dates roughly 18 months earlier. The scope draws together chemical separation, process stream and mass transfer claim language with phase separation and heat transfer terms, which is why refining, catalysis and biological synthesis all surface together.
Reading the field this way surfaces a market with a large, diffuse base of filers rather than a small cartel of blocking patents. That matters for freedom-to-operate work: the risk is less a handful of dominant estates and more a dense floor of overlapping mid-size portfolios across catalysis, hydrocarbon refining and biological purification routes.
Let an AI agent run this analysis on your own technology
Pick a task. Every answer cites the patents behind it.
Filing trend and technology composition
Two views of the same 11,323-record corpus: how filing volume has moved year over year, and how those records split across the IPC subclasses that define the field's technical center of gravity.
Filing trend, 2017–2026
Filings rose from 347 in 2017 to a peak of 388 in 2020, then eased to 330 in 2021 and 260 by 2024 — a 21% pullback over that span. 2025 and 2026 figures (down to 49 in 2026) reflect publication lag rather than an actual filing collapse, since publication trails filing by roughly 18 months.
Technology composition by IPC subclass
C07C acyclic/carbocyclic compounds (23.1% of records) and B01J catalysis (18.3%) anchor the field, with B01D separation processes (14.3%) close behind. Fermentation (C12P, 10.0%) and microorganism engineering (C12N, 7.1%) mark a distinct biological-route cluster running alongside the classical chemical-process claims; shares sum past 100% because records carry multiple IPC classes.
Shares are the percentage of the 11,323 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.
Go deeper on Separation & Purification Patent Landscape with Eureka
This page is one run against one query. Ask Eureka your own question about separation & purification patent landscape and every answer comes back with the patent numbers behind it.
Try EurekaThe most-cited prior art in this field
Devices with extended area structures for mass transfer processing of fluids
A microchannel device includes several mass transfer microchannels to receive a fluid media for processing at least one heat transfer microchannel in fluid communication with a heat transfer fluid defined by a thermally conductive wall, and at several thermally conductive fins each connected to the wall and extending therefrom to separate the mass transfer microchannels from one another. In one form, the device may optionally include another heat transfer microchannel and corresponding wall positioned opposite the first wall, with fins and mass transfer microchannels extending therebetween.US7520917B2, published 2009-04-21 — a Battelle Memorial Institute filing that anchors the microchannel mass-transfer sub-branch of this landscape.


| # | Publication no. | Patent title | Citations |
|---|---|---|---|
| 1 | US4016218A | Alkylation in presence of thermally modified crystalline aluminosilicate catalyst | 1,177 |
| 2 | US3769329A | Production of carboxylic acids and esters | 795 |
| 3 | US5650234A | Electrophilic polyethylene oxides for the modification of polysaccharides, polypeptides (proteins) and surfac… | 689 |
| 4 | US6627770B1 | Method and apparatus for sequesting entrained and volatile catalyst species in a carbonylation process | 646 |
| 5 | US5932100A | Microfabricated differential extraction device and method | 634 |
| 6 | US5498809A | Polymers derived from ethylene and 1-butene for use in the preparation of lubricant dispersant additives | 563 |
| 7 | WO2005037214A2 | Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of HCV replication | 523 |
| 8 | WO2008073186A2 | Processing biomass | 497 |
| 9 | US20190247050A1 | Integrated system for the infixion and retrieval of implants | 451 |
| 10 | US5942400A | Assays for detecting beta -secretase | 434 |
Citation counts favour older filings by construction — a 1970s alkylation patent will always out-cite a 2020 filing simply by having had more years to accumulate citations. Read these as markers of foundational influence, not current commercial relevance.
Each row carries its publication number; clicking a row searches Eureka by that number.
Put your own technology through the same analysis
Eureka on the web
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →MCP server & REST API
When it has to run inside your own pipeline.
Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.
Browse MCP servers →What the numbers mean for strategy
Three cuts of the same dataset that matter for different decisions: where filing volume sits today, how concentrated ownership is, and which citation anchors still shape freedom-to-operate analysis.
The post-2020 pullback is real, not a lag artefact
Filings dropped from 330 in 2021 to 260 in 2024 — both years clean of the ~18-month publication lag that understates 2025-2026. That is a genuine cooling after the 2020 peak of 388, not a data artefact.
No single estate controls the field
The leading assignee holds 689 records, but the top 5 combined account for only 14.2% of all 11,323 records in scope, and the top 10 reach just 19.8%. That is a long tail of mid-size and single-filing entrants, not a cartel.
Classical chemistry still leads, biological routes run alongside
C07C acyclic/carbocyclic compounds (23.1%) and B01J catalysis (18.3%) dominate, but C12P fermentation (10.0%) and C12N microorganisms (7.1%) mark a separately-claimed biological purification track worth tracking on its own terms.
Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to separation & purification patent landscape, with the prior art for and against each one.
Filers, collaboration patterns and where activity has stalled
The ranked leaders span integrated refiners, specialty chemical majors and a handful of microchannel-process specialists. Recent-year momentum data shows several previously active filers — including a microchannel-technology specialist and an integrated chemicals major — recording zero filings in the latest tracked year, a -100% year-on-year change consistent with the broader post-2021 pullback.
A clear leader, but not a dominant one
The top-ranked assignee holds 689 records against a field of 11,323 — enough to lead comfortably but far short of gatekeeping the space, given the top 5 combined sit at only 14.2% of all records.
Joint filing is concentrated in a few pairs
Ten co-assignee pairs appear in the data; the strongest pair co-files 42 records together, well ahead of the next strongest pairings at 23 and 11. This points to a small number of durable technical partnerships rather than a broad collaboration network.
Several established filers have gone quiet
Multiple assignees that were active earlier in the window — including a microchannel-process specialist and an integrated chemicals producer — show zero filings in the latest tracked year, with year-on-year changes as steep as -100%.
| Assignee | Recent year | YoY |
|---|---|---|
| Xyleco, Inc. | 0 | — |
| Eastman Chemical Company | 0 | -100% |
| Velocys, Inc. | 0 | — |
| ExxonMobil Chemical Patents Inc. | 0 | — |
| Celanese International Corporation | 0 | — |
| Battelle Memorial Institute | 0 | -100% |
| Grupo Petrotemex, S.A. de C.V. | 0 | — |
| Shell Oil Company | 0 | — |
Where to take this analysis
The landscape numbers point to specific next moves depending on whether the goal is freedom-to-operate clearance, licensing strategy or R&D prioritisation.
Map claim scope against the microchannel cluster
The most-cited records include microchannel mass-transfer and extraction devices — a technically narrow but heavily cited sub-branch worth a dedicated claim-chart pass before committing to hardware-based separation designs.
Explore claim scope in EurekaTrack the fermentation and microorganism track separately
C12P and C12N together mark a biological purification route that runs alongside the classical chemistry majority. Portfolios built there should be benchmarked against that sub-cluster, not the field average.
Run a sub-cluster search in EurekaWatch for renewed filing after the 2021-2024 pullback
The 21% drop from 2021 to 2024 is real, but publication lag means 2025-2026 data is still incomplete. Re-check filing momentum in 12-18 months before concluding the field has permanently cooled.
Set a filing-trend alert in EurekaCommon questions on separation & purification patents
The ranked leader in this dataset holds 689 records out of 11,323 total records in scope, giving it a clear lead but not control of the field. The top 5 assignees combined account for only 14.2% of all records, and the top 10 reach 19.8%, which means ownership is spread across a long tail of mid-size and single-filing entrants rather than concentrated in a few large estates. Anyone doing competitive tracking should watch the leader closely but also monitor the broader field, since most filing activity sits outside the top ranks.
Filings fell from 330 in 2021 to 260 in 2024, a 21% drop over that span, following a peak of 388 in 2020. That decline uses years that are clean of publication lag, so it reflects a genuine pullback rather than a data artefact. Figures for 2025 and 2026 look much lower still, but that is expected — publication lags filing by roughly 18 months, so those years will keep filling in and should not be read as confirming a further collapse.
C07C, covering acyclic and carbocyclic compounds, leads at 23.1% of the 11,323 records in scope, followed by B01J catalysis and physical processes at 18.3% and B01D separation processes at 14.3%. Fermentation (C12P) and microorganism engineering (C12N) each account for roughly 7-10% of records, marking a distinct biological purification track that runs alongside the classical chemical-process majority. Because records can carry multiple IPC classes, these shares add up to well over 100%, so they should be read as overlapping technical footprints rather than a strict market split.
US7520917B2 claims a microchannel device architecture combining mass-transfer microchannels with adjacent heat-transfer microchannels separated by thermally conductive fins extending from a shared wall. It is a representative filing from Battelle Memorial Institute in the microchannel mass-transfer sub-branch of this landscape, a cluster that also produces some of the field's most-cited prior art. Anyone designing microchannel-based separation or heat-exchange hardware should chart claims against this structural pattern specifically — the fin-and-wall geometry, not just the general microchannel concept — before finalising a design.
With the top 5 filers holding just 14.2% of all 11,323 records and the top 10 holding 19.8%, this field reads as fragmented compared to sectors with a dominant handful of blocking estates. That shallow concentration, combined with a leader holding 689 records against a fifth-place holder at 189 and a tenth-place holder at 99, suggests a field built on many overlapping mid-size portfolios rather than a small number of gatekeepers. Freedom-to-operate work here should expect to clear multiple mid-size portfolios rather than negotiate with one or two dominant holders.
Research Separation & Purification Patent Landscape in depth with Eureka
Go past this page: query the whole separation & purification patent landscape corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.
Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company’s registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.